Bicycle Therapeutics
+$0.93 (+6.20%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.
About BCYC
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles.
CEO
Kevin Lee
Employees
119
Headquarters
Cambridge, Cambridgeshire
Founded
2009
BCYC Key Statistics
Market cap
472.30M
Price-Earnings ratio
—
Dividend yield
—
Average volume
540.09K
High today
$16.13
Low today
$14.44
Open price
$15.00
Volume
577.48K
52 Week high
$62.08
52 Week low
$14.43
BCYC News
Analyst ratings
83%
of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
BCYC Earnings
-$0.93
-$0.62
-$0.31
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market